SEC Form 4 · accession 0000874015-15-000051
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley T Crooke
Officer — Chairman and CEO · Director
Period of report
Apr 7, 2015
Accepted (ET)
Apr 8, 2015 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2015 | M | 20,343 | $11.27 | A | 34,985 | D | |
| Common StockF1 | Apr 7, 2015 | S | 20,343 | $63.071 | D | 14,642 | D | |
| Common StockF2 | Apr 7, 2015 | M | 2,034 | $9.22 | A | 3,331 | I | By wife |
| Common StockF2 | Apr 7, 2015 | S | 2,034 | $63.071 | D | 1,297 | I | By wife |
| Common Stock | holding | — | — | — | 725,391 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $11.27 | Apr 7, 2015 | M | 20,343 | D | Jan 4, 2014 | Jan 3, 2017 | Common Stock | 20,343 | 29,163 | D |
| Employee Stock Option (right to buy) | $9.22 | Apr 7, 2015 | M | 2,034 | D | Jul 19, 2014 | Jul 18, 2017 | Common Stock | 2,034 | 7,350 | I |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/6/2013.
- F2Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 8/6/2013.